EAM
Exane Asset Management Portfolio holdings
AUM
$256M
This Quarter Return
+8.23%
1 Year Return
+8.08%
3 Year Return
+70.48%
5 Year Return
+81.39%
10 Year Return
–
AUM
$512M
AUM Growth
+$512M
(+60%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
33.05%
Top 10 Holdings %
Top 10 Hldgs %
57.05%
Holding
170
New
64
Increased
33
Reduced
12
Closed
56
Top Buys
| 1 |
AT&T
T
|
$32.2M |
| 2 |
Verizon
VZ
|
$27.3M |
| 3 |
CNH
CNH Industrial
CNH
|
$23.9M |
| 4 |
Ecovyst
ECVT
|
$23.5M |
| 5 |
Liberty Global Class A
LBTYA
|
$19.9M |
Top Sells
| 1 |
MON
Monsanto Co
MON
|
$19.9M |
| 2 |
GCP
GCP Applied Technologies Inc.
GCP
|
$19M |
| 3 |
CELG
Celgene Corp
CELG
|
$13.2M |
| 4 |
Axalta
AXTA
|
$8.65M |
| 5 |
Wells Fargo
WFC
|
$6.93M |
Sector Composition
| 1 | Healthcare | 35.07% |
| 2 | Materials | 23.96% |
| 3 | Communication Services | 22.18% |
| 4 | Industrials | 8.02% |
| 5 | Financials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $45.3M | 8.86% |
559,587
+225,985
| +68% | +$18.3M |
|
2
Qiagen
QGEN
$10.1B
| $37.4M | 7.3% |
1,187,268
+548,400
| +86% | +$17.3M |
|
|
3
AT&T
T
$209B
| $32.3M | 6.32% |
825,685
+823,229
| +33,519% | +$32.2M |
|
4
Bristol-Myers Squibb
BMY
$96B
| $30.2M | 5.9% |
473,761
-80,601
| -15% | -$5.14M |
|
|
5
Verizon
VZ
$186B
| $27.5M | 5.38% |
555,860
+551,701
| +13,265% | +$27.3M |
|
6
Ashland
ASH
$2.57B
| $24.7M | 4.83% |
378,178
+101,463
| +37% | +$6.63M |
|
|
CNH
7
CNH Industrial
CNH
$14.3B
| $23.9M | 4.67% |
+1,988,968
| New | +$23.9M |
|
8
Air Products & Chemicals
APD
$65.5B
| $23.6M | 4.61% |
155,811
+3,182
| +2% | +$481K |
|
|
9
Ecovyst
ECVT
$1.04B
| $23.5M | 4.6% |
+1,363,925
| New | +$23.5M |
|
10
Biogen
BIIB
$19.4B
| $23.5M | 4.59% |
74,948
+8,826
| +13% | +$2.76M |
|
|
11
Liberty Global Class A
LBTYA
$4B
| $21.8M | 4.26% |
643,336
+586,350
| +1,029% | +$19.9M |
|
12
TIM SA
TIMB
$10.2B
| $21.4M | 4.18% |
1,169,592
-116,744
| -9% | -$2.13M |
|
13
CF Industries
CF
$14B
| $15.3M | 2.99% |
+435,541
| New | +$15.3M |
|
14
Olin
OLN
$2.71B
| $15M | 2.92% |
436,579
+186,526
| +75% | +$6.39M |
|
|
UNVR
15
DELISTED
Univar Solutions Inc.
UNVR
| $14.4M | 2.81% |
+497,656
| New | +$14.4M |
|
16
Bank of America
BAC
$376B
| $12.7M | 2.48% |
500,000
| – | – |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.2M | 2.19% |
79,865
-12,908
| -14% | -$1.81M |
|
18
BioMarin Pharmaceuticals
BMRN
$11.2B
| $11.2M | 2.19% |
+120,200
| New | +$11.2M |
|
19
Merck
MRK
$210B
| $10M | 1.96% |
+156,868
| New | +$10M |
|
20
Citigroup
C
$178B
| $9.09M | 1.78% |
125,000
| – | – |
|
|
DBVT
21
DBV Technologies
DBVT
$264M
| $6.07M | 1.19% |
143,000
| – | – |
|
22
PACCAR
PCAR
$52.5B
| $5.12M | 1% |
70,832
-1,461
| -2% | -$106K |
|
23
NXP Semiconductors
NXPI
$59.2B
| $4.62M | 0.9% |
40,840
+19,440
| +91% | +$2.2M |
|
|
TWX
24
DELISTED
Time Warner Inc
TWX
| $4.5M | 0.88% |
+43,900
| New | +$4.5M |
|
|
MON
25
DELISTED
Monsanto Co
MON
| $4.01M | 0.78% |
33,500
-166,010
| -83% | -$19.9M |
|